Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain

Peptides

Volumn 31, Issue 7, 2010, Pages 1374-1382

  Wu, Chun Hung ^a   Tao, Pao Luh ^a   Huang, Eagle Yi Kung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Conditioned place preference (CPP); Dopamine; GABA; Mesolimbic pathway; Morphine; Neuropeptide FF (NPFF)

Indexed keywords

DOPAMINE; GLUTAMATE DECARBOXYLASE 67; MORPHINE; NEUROPEPTIDE FF; NEUROPEPTIDE FF RECEPTOR; NEUROPEPTIDE RECEPTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; GABAERGIC SYSTEM; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; VENTRAL TEGMENTUM;

ANALGESICS, OPIOID; ANIMALS; BRAIN; GLUTAMATE DECARBOXYLASE; MALE; MORPHINE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; REWARD; VENTRAL TEGMENTAL AREA;

RATTUS;

EID: 77952518197     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.036     Document Type: Article

References (33)

1. Allard M., Geoffre S., Legendre P., Vincent J.D., and Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res 500 (1989) 169-176
2. Allard M., Zajac J.M., and Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 49 (1992) 101-116
3. Anko M.L., Ostergard M., Lintunen M., and Panula P. Alternative splicing of human and mouse NPFF2 receptor genes: Implications to receptor expression. FEBS Lett 580 (2006) 6955-6960
4. Askwith C.C., Cheng C., Ikuma M., Benson C., Price M.P., and Welsh M.J. Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. Neuron 26 (2000) 133-141
5. Atherton EaS R.C. Solid phase peptide synthesis: a practical approach (1989), Oxford
6. Attila M., Kurkijarvi U., Kivipelto L., Panula P., and Ahtee L. The antiopioid peptide, neuropeptide FF, enhances the effects of acute morphine on the cerebral monoamines in rats. Pharmacol Res 32 (1995) 293-298
7. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
8. Catarsi S., Babinski K., and Seguela P. Selective modulation of heteromeric ASIC proton-gated channels by neuropeptide FF. Neuropharmacology 41 (2001) 592-600
9. Dupouy V., and Zajac J.M. Neuropeptide FF receptors in rat brain: a quantitative light-microscopic autoradiographic study using [125I][D.Tyr1, (NMe)Phe3]NPFF. Synapse 24 (1996) 282-296
10. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275 (2000) 25965-25971
11. Gouarderes C., Mazarguil H., Mollereau C., Chartrel N., Leprince J., Vaudry H., et al. Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding. Neuropharmacology 52 (2007) 376-386
12. Gouarderes C., Sutak M., Zajac J.M., and Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 237 (1993) 73-81
13. Gouarderes C., Tafani J.A., and Zajac J.M. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides 19 (1998) 727-730
14. Huang E.Y., Li J.Y., Wong C.H., Tan P.P., and Chen J.C. Dansyl-PQRamide, a possible neuropeptide FF receptor antagonist, induces conditioned place preference. Peptides 23 (2002) 489-496
15. Huang E.Y., Liu T.C., and Tao P.L. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol 368 (2003) 386-392
16. Kotlinska J., Pachuta A., Dylag T., and Silberring J. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats. Peptides 28 (2007) 2235-2242
17. Kotlinska J., Pachuta A., and Silberring J. Neuropeptide FF (NPFF) reduces the expression of cocaine-induced conditioned place preference and cocaine-induced sensitization in animals. Peptides 29 (2008) 933-939
18. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.Y., and Malin D.H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 132 (1991) 29-32
19. Lake J.R., Hebert K.M., Payza K., Deshotel K.D., Hausam D.D., Witherspoon W.E., et al. Analog of neuropeptide FF attenuates morphine tolerance. Neurosci Lett 146 (1992) 203-206
20. 2 like mammalian octapeptide in opiate dependence and withdrawal. NIDA Res Monogr 105 (1990) 271-277
21. 2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 11 (1990) 969-972
22. Malin D.H., Lake J.R., Leyva J.E., Hammond M.V., Rogillio R.B., Arcangeli K.R., et al. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides 12 (1991) 1011-1014
23. Malin D.H., Lake J.R., Payza K., Corriere L.S., Benson T.M., Garber T.L., et al. Enhanced antiopiate activity and enzyme resistance in peptidomimetics of FMRFamide containing (E)-2,3-methanomethionine. Peptides 14 (1993) 731-734
24. Malin D.H., Lake J.R., Smith D.A., Jones J.A., Morel J., Claunch A.E., et al. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug Alcohol Depend 40 (1995) 37-42
25. Marchand S., Betourne A., Marty V., Daumas S., Halley H., Lassalle J.M., et al. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice. Peptides 27 (2006) 964-972
26. Marco N., Stinus L., Allard M., Le Moal M., and Simonnet G. Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: localization and functional antiopioid involvement. Neuroscience 64 (1995) 1035-1044
27. Oberling P., Stinus L., Le Moal M., and Simonnet G. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides 14 (1993) 919-924
28. Panula P., Aarnisalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48 (1996) 461-487
29. Raffa R.B., Kim A., Rice K.C., de Costa B.R., Codd E.E., and Rothman R.B. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors. Peptides 15 (1994) 401-404
30. Robbins T.W., Cador M., Taylor J.R., and Everitt B.J. Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev 13 (1989) 155-162
31. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56 (1998) 613-672
32. Yang H.Y., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82 (1985) 7757-7761
33. Yang H.Y., and Iadarola M.J. Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides 27 (2006) 943-952